Guangdong Provincial People's Hospital

This study tests a new drug combination (ABC-14) for adults newly diagnosed with acute myeloid leukemia (AML). It compares the new combo to standard chemotherapy or another two-drug regimen. The goal is to see if the new approach leads to more complete remissions with fewer side …

This study tests whether adding Qishen Yiqi Dropping Pills to standard drug therapy helps people with severe pulmonary hypertension. About 120 adults will be randomly assigned to receive either the combination or standard therapy alone for 52 weeks. Researchers will measure chang…

This study tests a new long-acting drug called pegmolesatide for anemia in people with chronic kidney disease who are on dialysis and already taking another anemia medication. The goal is to see if switching to this drug is safe and effective. About 96 adults will take the drug f…

This study tests whether a smartphone app that gives personalized diet and exercise advice can help people with both coronary heart disease and obesity lose weight. About 140 adults aged 18-65 will use the app and a Bluetooth scale to track their progress. The goal is to see if t…

This study tests whether taking aspirin can safely lower the risk of heart attacks, strokes, and heart-related death in people with kidney failure who are on dialysis. About 9,000 adults will be randomly assigned to take aspirin or not, and researchers will track their heart heal…

This study tests Yiyuancong, a traditional Chinese medicine formula, for sudden sensorineural hearing loss. About 128 adults aged 18-60 will take the herbal remedy for 1-2 months, and researchers will measure hearing improvements using standard hearing tests. The goal is to see i…

This study is testing a new AI system that can look at photos of the eye and diagnose diseases. The goal is to help doctors make faster and more accurate diagnoses. About 2000 people with and without eye problems will take part. The AI's diagnoses will be compared to those made b…

This study tests whether a community-based exercise program can improve exercise capacity in 200 adults aged 18-85 with reduced heart or lung function. Participants will do 40-60 minutes of exercise (like brisk walking or cycling) five times a week for eight weeks. Researchers wi…

This study tests whether a tablet called nalfurafine hydrochloride can safely reduce moderate-to-severe itching in people undergoing peritoneal dialysis for kidney failure. About 93 participants will take the tablet daily for 4 weeks, and researchers will measure changes in itch …

This study is a registry that collects information from children and teens diagnosed with pulmonary hypertension (high blood pressure in the lungs). Researchers will follow their health over time to see how the disease progresses, how treatments work, and what affects long-term o…

This study is following 90,000 people in China, including those with and without chronic kidney disease (CKD), to see how the disease develops and gets worse over time. Researchers will track changes in kidney function and other health markers. The goal is to learn more about CKD…

This study checks if artificial intelligence (AI) can create questions for the Chinese medical licensing exam that are as good as those written by human experts. Twenty medical students will answer both AI-generated and human-written questions without knowing which is which. The …